Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects

Details for Australian Patent Application No. 2010257389 (hide)

Owner Centelion

Inventors Caron, Alexis; Emmanuel, Florence; Caron, Anne; Finiels, Francoise; Schwartz, Bertrand; Rouy, Didier; Branellec, Didier; Michelet, Sandrine

Agent Middletons

Pub. Number AU-A-2010257389

Parent 2004244756

Filing date 22 December 2010

Wipo publication date 27 January 2011

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

20 January 2011 Complete Application Filed

27 January 2011 Application Open to Public Inspection

  Published as AU-A-2010257389

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010257390-Catheter with arcuate end section

2010257388-Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods